Building Organoids to Combat Cancer

Ankur Singh and Shivem Shah

Shivem Shah is one of a new generation of scientists who are developing therapies that will modulate the immune system to combat disease. They are called immunoengineers. A fourth-year biomedical engineering PhD Student, Shah first became interested in biomedical engineering because of the opportunity to create therapies for diseases with inadequate treatments. He is specifically drawn to immunoengineering for its potential to treat and possibly even cure diseases with poor prognosis, such as cancer.

Read more on Cornell Research

More Spotlights